- Home
- NA vs IOBT Comparison
NA vs IOBT Comparison
Compare NA & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NA
- IOBT
- Stock Information
- Founded
- NA 2019
- IOBT 2014
- Country
- NA China
- IOBT Denmark
- Employees
- NA N/A
- IOBT N/A
- Industry
- NA Semiconductors
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- NA Technology
- IOBT Health Care
- Exchange
- NA Nasdaq
- IOBT Nasdaq
- Market Cap
- NA 77.6M
- IOBT 79.7M
- IPO Year
- NA 2022
- IOBT 2021
- Fundamental
- Price
- NA $12.17
- IOBT $1.29
- Analyst Decision
- NA
- IOBT Strong Buy
- Analyst Count
- NA 0
- IOBT 3
- Target Price
- NA N/A
- IOBT $9.33
- AVG Volume (30 Days)
- NA 390.5K
- IOBT 233.4K
- Earning Date
- NA 03-25-2025
- IOBT 08-12-2025
- Dividend Yield
- NA N/A
- IOBT N/A
- EPS Growth
- NA N/A
- IOBT N/A
- EPS
- NA N/A
- IOBT N/A
- Revenue
- NA $5,561,770.00
- IOBT N/A
- Revenue This Year
- NA N/A
- IOBT N/A
- Revenue Next Year
- NA N/A
- IOBT N/A
- P/E Ratio
- NA N/A
- IOBT N/A
- Revenue Growth
- NA N/A
- IOBT N/A
- 52 Week Low
- NA $2.75
- IOBT $0.66
- 52 Week High
- NA $13.86
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- NA 76.74
- IOBT 49.63
- Support Level
- NA $7.75
- IOBT $1.26
- Resistance Level
- NA $12.94
- IOBT $1.57
- Average True Range (ATR)
- NA 1.91
- IOBT 0.13
- MACD
- NA 0.44
- IOBT -0.04
- Stochastic Oscillator
- NA 88.48
- IOBT 19.46
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.